Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Add To Watchlist

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Somethings smells here

View:

Post by Viking2233 on Jun 28, 2023 8:31pm

Somethings smells here

Yesterday's new release of FDA approval for AKI phase 2 trial should have caught the attention of any interested investors. IMO yesterdays news should have got us back up to $5 with high volume. We had a mild bump up Monday and Tuesday (news release) to the tune of 15%. Today CIBC and Scotiabank knocked us on our a.. today closing down 5.25%. Something fishy here.

Just the mention of FDA would spark buying interest.

The other intresting point is there are multiple similar staged companies who have market caps of $1B to $2B and we are stuck at $125M. We know we have the science but why the major difference?? Something is not adding up here? Where are the buyers?

159